
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| MB_ML_R | 149 | 42.8% | 0.76 | 252 | 44.7% |
| MB_VL_R | 53 | 15.2% | 1.41 | 141 | 25.0% |
| CRE_R | 67 | 19.3% | 0.70 | 109 | 19.3% |
| MB_CA_R | 53 | 15.2% | -1.34 | 21 | 3.7% |
| SIP_R | 11 | 3.2% | 0.71 | 18 | 3.2% |
| MB_PED_R | 7 | 2.0% | 1.51 | 20 | 3.5% |
| SMP_R | 3 | 0.9% | 0.00 | 3 | 0.5% |
| PLP_R | 4 | 1.1% | -inf | 0 | 0.0% |
| SCL_R | 1 | 0.3% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCa'b'-ap1 | % In | CV |
|---|---|---|---|---|---|
| KCapbp-ap1 (R) | 75 | ACh | 140 | 42.6% | 0.7 |
| KCa'b'-ap1 (R) | 1 | ACh | 24 | 7.3% | 0.0 |
| KCg-m (R) | 13 | ACh | 21 | 6.4% | 1.0 |
| VA5_lPN (R) | 1 | ACh | 20 | 6.1% | 0.0 |
| APL (R) | 1 | GABA | 20 | 6.1% | 0.0 |
| PAM05 (R) | 7 | DA | 17 | 5.2% | 0.8 |
| DPM (R) | 1 | DA | 11 | 3.3% | 0.0 |
| KCapbp-ap2 (R) | 11 | ACh | 11 | 3.3% | 0.0 |
| PAM05 (L) | 4 | DA | 10 | 3.0% | 0.6 |
| VA7m_lPN (R) | 1 | ACh | 9 | 2.7% | 0.0 |
| MB-C1 (R) | 2 | GABA | 7 | 2.1% | 0.7 |
| PAM13 (L) | 4 | DA | 7 | 2.1% | 0.2 |
| PAM13 (R) | 4 | DA | 5 | 1.5% | 0.3 |
| VL2p_adPN (R) | 1 | ACh | 4 | 1.2% | 0.0 |
| PPL103 (L) | 1 | DA | 3 | 0.9% | 0.0 |
| VM5v_adPN (R) | 1 | ACh | 3 | 0.9% | 0.0 |
| MBON10 (R) | 2 | GABA | 3 | 0.9% | 0.3 |
| PPL103 (R) | 1 | DA | 2 | 0.6% | 0.0 |
| PAM08 (L) | 1 | DA | 2 | 0.6% | 0.0 |
| MBON04 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| PAM06 (R) | 1 | DA | 1 | 0.3% | 0.0 |
| MBON01 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 1 | 0.3% | 0.0 |
| KCab-p (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| MBON03 (L) | 1 | Unk | 1 | 0.3% | 0.0 |
| MBON12 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| MBON05 (L) | 1 | Unk | 1 | 0.3% | 0.0 |
| KCab (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns KCa'b'-ap1 | % Out | CV |
|---|---|---|---|---|---|
| KCapbp-ap1 (R) | 80 | ACh | 140 | 31.8% | 0.7 |
| DPM (R) | 1 | DA | 43 | 9.8% | 0.0 |
| APL (R) | 1 | GABA | 30 | 6.8% | 0.0 |
| KCa'b'-ap1 (R) | 1 | ACh | 24 | 5.5% | 0.0 |
| KCg-m (R) | 15 | ACh | 19 | 4.3% | 0.6 |
| KCapbp-ap2 (R) | 17 | ACh | 19 | 4.3% | 0.3 |
| PAM05 (R) | 7 | DA | 15 | 3.4% | 0.5 |
| MBON03 (L) | 1 | Unk | 12 | 2.7% | 0.0 |
| MBON09 (L) | 2 | GABA | 12 | 2.7% | 0.0 |
| MBON31 (R) | 1 | GABA | 11 | 2.5% | 0.0 |
| MBON12 (R) | 2 | ACh | 11 | 2.5% | 0.6 |
| PAM13 (L) | 6 | DA | 11 | 2.5% | 0.2 |
| MBON04 (L) | 1 | Glu | 10 | 2.3% | 0.0 |
| PAM13 (R) | 4 | DA | 10 | 2.3% | 0.4 |
| MBON10 (R) | 4 | GABA | 8 | 1.8% | 0.5 |
| PPL103 (L) | 1 | DA | 7 | 1.6% | 0.0 |
| PPL103 (R) | 1 | DA | 6 | 1.4% | 0.0 |
| MBON26 (R) | 1 | ACh | 6 | 1.4% | 0.0 |
| PAM02 (R) | 3 | Unk | 6 | 1.4% | 0.4 |
| PAM05 (L) | 3 | DA | 5 | 1.1% | 0.3 |
| MBON32 (R) | 1 | Unk | 4 | 0.9% | 0.0 |
| MBON01 (L) | 1 | Glu | 3 | 0.7% | 0.0 |
| PAM02 (L) | 2 | DA | 3 | 0.7% | 0.3 |
| PPL104 (R) | 1 | DA | 2 | 0.5% | 0.0 |
| PPL104 (L) | 1 | DA | 2 | 0.5% | 0.0 |
| MBON16 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| MBON13 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| MBON05 (L) | 1 | Unk | 2 | 0.5% | 0.0 |
| PAM14 (L) | 1 | Unk | 2 | 0.5% | 0.0 |
| PAM14 (R) | 1 | DA | 2 | 0.5% | 0.0 |
| KCab (R) | 2 | ACh | 2 | 0.5% | 0.0 |
| PAM08 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| MBON30 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| PAM06 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| CB2945 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| PAM08 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| PPL101 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| MBON11 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| KCg-d (R) | 1 | ACh | 1 | 0.2% | 0.0 |